Effectively Conducting Oncology Clinical Trials During the COVID-19 Pandemic.
Journal
Advances in radiation oncology
ISSN: 2452-1094
Titre abrégé: Adv Radiat Oncol
Pays: United States
ID NLM: 101677247
Informations de publication
Date de publication:
Historique:
received:
08
02
2021
accepted:
11
02
2021
pubmed:
10
3
2021
medline:
10
3
2021
entrez:
9
3
2021
Statut:
ppublish
Résumé
Clinical trial enrollment has declined globally as a result of the coronavirus disease 2019 (COVID-19) pandemic. This underscores the importance of structured methods to continue critical medical research safely and efficiently. We report the effect of a phased trial reopening strategy, remote research staffing, and telemedicine on cancer trial enrollment at one of the largest radiation oncology academic cancer centers. In phase 1, trials investigating definitive therapeutic benefit were opened, followed by trials not increasing patient exposure or pulmonary toxicity risk in phase 2. During phase 2.5, multicenter trials reopened and limited research staff were allowed on site. Despite initial enrollment declines during the early pandemic, the percentage of new patients enrolling in clinical trials from March to August 2020 was 8.8%, and represented a 10.5% relative increase from 2019. Monthly accrual enrollment from March to August 2019 ranged from 42 to 71, compared with enrollment during COVID-19 from 23 to 73 patients ( Through a phased approach to trial reopening and adaptive techniques, the division of radiation oncology maintained cancer trial accrual during the COVID-19 pandemic. The experience may help centers maintain accrual, preserve clinical trial integrity, and minimize risk to patients and staff.
Identifiants
pubmed: 33686374
doi: 10.1016/j.adro.2021.100676
pii: S2452-1094(21)00034-8
pmc: PMC7927592
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100676Informations de copyright
© 2021 The Authors.
Références
Dermatology. 2020;236(4):375-382
pubmed: 32126560
JAMA. 2020 Jun 2;323(21):2135-2136
pubmed: 32211830
Clin Trials. 2015 Feb;12(1):77-83
pubmed: 25475878
NPJ Digit Med. 2020 Jul 31;3:101
pubmed: 32821856
Am Soc Clin Oncol Educ Book. 2018 May 23;38:540-545
pubmed: 30231354
J Dermatolog Treat. 2020 Jun;31(4):330-332
pubmed: 32343162
Clin Cancer Res. 2020 Jul 1;26(13):3100-3103
pubmed: 32312892
J Oncol Pract. 2019 Apr;15(4):e289-e299
pubmed: 30830833
Head Neck. 2020 Jul;42(7):1516-1518
pubmed: 32348582
JAMA. 2020 Jul 7;324(1):33-34
pubmed: 32463422
J Natl Cancer Inst. 2020 Sep 22;:
pubmed: 32959883